Literature DB >> 8343498

Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL cholesterol.

B Blades1, G L Vega, S M Grundy.   

Abstract

Previous investigations have shown that abnormalities in the postheparin plasma levels of the lipolytic enzymes, lipoprotein lipase (LPL) and hepatic triglyceride lipase (HTGL), are correlated with variations in plasma high-density lipoprotein cholesterol (HDL-C) levels. The present study was performed to determine correlations between the postheparin plasma activities of these two enzymes and HDL levels in a sizable number of subjects with low HDL-C levels. Two types of low-HDL subjects were investigated: 159 male subjects with low HDL-C (< 40 mg/dL) and normal triglyceride (< 250 mg/dL) levels (the low-HDL group) and 80 male subjects with low HDL-C (< 40 mg/dL) and elevated triglyceride (> or = 250 mg/dL) levels (the low-HDL/high-TG group). Postheparin plasma activities of LPL and HTGL were determined in these two groups, and these levels were compared with those obtained from 51 normolipidemic (normal-HDL) male subjects. Postheparin LPL activities were significantly lower in the low-HDL and low-HDL/high-TG groups (mean +/- SD, 9.9 +/- 2.9 and 10.4 +/- 3.0 mmol/h per liter, respectively; P < .001 for both) compared with the normal-HDL group (12.5 +/- 3.7 mmol/h per liter). Conversely, postheparin HTGL activities were significantly higher in the low-HDL and low-HDL/high-TG groups (39.3 +/- 16.2 and 44.4 +/- 16.7 mmol/h per liter, respectively; P < .001 for both) compared with the normal-HDL group (29.7 +/- 11.3 mmol/h per liter). Consequently, mean LPL/HTGL ratios were markedly lower in the two low-HDL groups compared with the normal-HDL group.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8343498     DOI: 10.1161/01.atv.13.8.1227

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  19 in total

1.  Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.

Authors:  J C Cohen; Z Wang; S M Grundy; M R Stoesz; R Guerra
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

2.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators.

Authors:  E Tahvanainen; M Syvanne; M H Frick; S Murtomaki-Repo; M Antikainen; Y A Kesaniemi; H Kauma; A Pasternak; M R Taskinen; C Ehnholm
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

3.  Ethnicity, obesity and the metabolic syndrome: implications on assessing risk and targeting intervention.

Authors:  Mark D Deboer
Journal:  Expert Rev Endocrinol Metab       Date:  2011-03

4.  Inflammatory, lipid, and body composition responses to interval training or moderate aerobic training.

Authors:  David J Elmer; Richard H Laird; Matthew D Barberio; David D Pascoe
Journal:  Eur J Appl Physiol       Date:  2015-12-31       Impact factor: 3.078

5.  Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.

Authors:  N Srivastava; P R Chowdhury; M Averna; R A Srivastava
Journal:  Mol Cell Biochem       Date:  2001-04       Impact factor: 3.396

Review 6.  Human genetics of variation in high-density lipoprotein cholesterol.

Authors:  Atif Qasim; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

7.  Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.

Authors:  P Knudsen; J Eriksson; S Lahdenperä; J Kahri; L Groop; M R Taskinen
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

8.  Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM.

Authors:  C M Forsblom; J G Eriksson; A V Ekstrand; A M Teppo; M R Taskinen; L C Groop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 9.  Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk.

Authors:  Jila Kaberi Otarod; Ira J Goldberg
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

10.  The rs2070895 (-250G/A) Single Nucleotide Polymorphism in Hepatic Lipase (HL) Gene and the Risk of Coronary Artery Disease in North Indian Population: A Case-Control Study.

Authors:  Pratima Verma; Dileep Kumar Verma; Rishi Sethi; Shraddha Singh; Akhilesh Krishna
Journal:  J Clin Diagn Res       Date:  2016-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.